🏅 FDA Orphan Designation
Photrexa Viscous
riboflavin ophthalmic solution & ultraviolet A
Manufacturer: Glaukos Corporation
Indicated for:
FDA-Approved Indications (1)
Indicated for use in corneal collagen crosslinking in combination with the KXL System for the treatment of progressive keratoconus
Population: all ages
Indications & Usage
Indicated for use in corneal collagen crosslinking in combination with the KXL� System for the treatment of progressive keratoconus ||| Treatment of corneal ectasia following refractive surgery
💙 Support Programs
View all →Photrexa Viscous
Glaukos Corporation
Photrexa Viscous
Glaukos Corporation
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.